Getting to stage 3 is a huge accomplishment. Here is an average for all studies on the success at passing stages :
passing Phase 1 : 63%
passing Phase 2 : 31%
passing Phase 3 : 58%
Approval : 85%
So getting past phase 2 is the hardest thing. Downhill from there. And if we have got to stage 3 for one treatment, the likelyhood is greater for other similar treatments.
ref : https://www.bio.org/sites/default/f...6-2015 - BIO, Biomedtracker, Amplion 2016.pdf
- Forums
- ASX - By Stock
- QIN
- Take over, Call me craxy
Take over, Call me craxy, page-2
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add QIN (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online